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Disorders of neuronal mispositioning during brain development are phenotypically
heterogeneous and their genetic causes remain largely unknown. Here, we report
biallelic variants in a Hippo signaling factor—MOB2—in a patient with one such
disorder, periventricular nodular heterotopia (PH). Genetic and cellular analysis of both
variants confirmed them to be loss-of-function with enhanced sensitivity to transcript
degradation via nonsense mediated decay (NMD) or increased protein turnover via the
proteasome. Knockdown of Mob2 within the developing mouse cortex demonstrated its
role in neuronal positioning. Cilia positioning and number within migrating neurons was
also impaired with comparable defects detected following a reduction in levels of an
upstream modulator of Mob2 function, Dchs1, a previously identified locus associated
with PH. Moreover, reduced Mob2 expression increased phosphorylation of Filamin A,
an actin cross-linking protein frequently mutated in cases of this disorder. These results
reveal a key role for Mob2 in correct neuronal positioning within the developing cortex
and outline a new candidate locus for PH development.
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INTRODUCTION
During mammalian brain development, new neurons are produced from germinal niches lining
the lateral ventricles of the cerebral cortex. From here, neurons must migrate to the outer cortical
plate (CP), where they establish connections, contributing to normal brain function (Götz and
Huttner, 2005). Broadly grouped, these crucial processes begin with neurogenesis, followed by
neuronal migration, differentiation and spatial organization to establish connectivity (Komuro
and Rakic, 1998; Kriegstein and Noctor, 2004). Disruption of these developmental processes can
lead to a range of neurodevelopment conditions, the understanding of which can inform on the
mechanisms governing normal brain development.
Periventricular nodular heterotopia (PH) is a phenotypically heterogeneous condition
of cortical development characterized by a failure of neurons to populate the outer cortex
of the brain, resulting in heterotopic positioning along their sites of origin—the margins of
the lateral ventricles (Guerrini and Dobyns, 2014). Although variants in eight genes have been
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shown to cause PH, these only account for ∼26% of sporadic
cases (Fox et al., 1998; Sheen et al., 2004; Parrini et al., 2006;
Cappello et al., 2013; Conti et al., 2013; Broix et al., 2016;
Alcantara et al., 2017; Oegema et al., 2017). An important
etiological role for genetics is, however, hypothesized in many
of the remaining individuals with PH (Mandelstam et al., 2013).
Mutations in the gene FLNA, encoding the F-actin binding
protein FilaminA, represent the main cause for established
monogenic forms of PH accounting for almost all familial
X-linked presentations (Fox et al., 1998). A rare autosomal
recessive form of PH with associated microcephaly has also
been described in six individuals (Sheen et al., 2004; Bardón-
Cancho et al., 2014). The causative gene associated with this
phenotype is ARFGEF2, with all mutations to date being loss-of-
function. In vitro studies have shown that ARFGEF2, encoding
ADP-ribosylation factor guanine nucleotide exchange factor
2 (or BIG2), regulates vesicle formation from the Golgi and
trafficking to the cellular surface. BIG2 is also reported to regulate
the transport of FLNA to its appropriate cellular compartment
(Shin et al., 2005).
Mutations in the atypical cadherin receptor ligands FAT4
and DCHS1 have also been shown to cause PH (Cappello
et al., 2013). FAT4 and DCHS1 function upstream of the
MST kinase (aka Hippo) of the Hippo signaling pathway to
control two main functions—cellular polarity and proliferation;
with nuclear YAP promoting cell proliferation. Although much
interest in recent years has focused on the function of the
MST kinases and their downstream effectors—NDR1/2 and
Yap (Hergovich, 2012), the heterotopic neurons produced upon
FAT4 and DCHS1 knockdown could be mitigated by the
simultaneous knockdown of Yap (Cappello et al., 2013). These
results suggested that disrupted proliferation was the dominant
mechanism for the altered neuronal distribution. However, a
role for NDR1/2, a separate branch of the Hippo signaling
pathway, could also be involved, but as yet, this possibility
remains unexplored. Most recently, missense mutations leading
to substitutions in the HECT domain of the E3 ubiquitin ligase,
NEDD4L, were also implicated in the cause of PH with in vivo
mouse studies highlighting dysregulation of mTOR and AKT
signaling pathways (Broix et al., 2016).
In this study, we hypothesized that existing knowledge of
the genetic pathways underpinning PH could be exploited
to prioritize variants found in the genes of patients with
PH by exome sequencing. Although such genes fall short of
proof-of-pathogenicity on genetic grounds, the aim of this
strategy is to identify candidate genes with experimentally
validated deleterious biallelic variants for more in-depth targeted
re-sequencing analyses that further test their causative potential
of PH.
MATERIALS AND METHODS
Subject Ascertainment and Ethical
Approval
All study participants were ascertained by physician-initiated
referral and consented to participate under a University of
Otago consent protocol. Ethical approval was obtained from
the Southern Regional Ethics Committee O03/016 and the New
Zealand Multicenter Ethics Committee MEC08/08/094.
Whole-Exome Sequencing
Whole-exome sequencing was carried out by Otogenetics
Corporation (Norcross, GA, USA). Sequencing libraries were
prepared from genomic DNA extracted from leukocytes of
parents and patients using Wizardr Genomic DNA Purification
Kit (Promega, Cat. A1620) following the manufacturer’s
instructions. Library DNA was exome enriched using the
Agilent SureSelect Human All Exon V4+UTRs capture kit, and
sequenced on an Illumina Hiseq2000, Illumina, San Diego,
CA, USA using 100 bp paired-end reads. Alignment of the
sequenced DNA fragments to the Ensembl Genome Browser
human genome assembly (GRCh37) was carried out using
the Burrows-Wheeler Aligner (MEM algorithm) v.0.7.12. After
alignments were produced for each individual separately, the
data was locally realigned around indels followed by base
quality score recalibration consistent with GenomeAnalysis Tool
Kit (GATK) Best Practices (version 3.4–46; Broad Institute).
Duplicate reads were removed using PICARD (version 1.140;
Broad Institute). Individual variant calling was undertaken using
the GATK HaplotypeCaller, followed by joint genotyping and
variant quality score recalibration to produce a multisample
variant call format file (vcf).
VCF gene context annotation was added using SnpEff
v.4.1L. Allele frequencies were obtained from 1000 Genomes
Project phase 1, NHLBI GO Exome Sequencing Project (ESP)
ESP6500 and the Exome Aggregation Consortium (ExAC) via
the GATK VariantAnnotator. All alignments with loci bearing
putative de novo variants were extracted from the multisample
VCF using GATK SelectVariants and SnpSift v.4.1L (SnpEff) that
met the following criteria: (1) the read depth should be≥8 within
the patient; (2) at least 20% of the reads should carry the alternate
allele; (3) <5% of the reads in either parent should carry the
alternative allele; (4) at least two alleles must be observed in the
proband; (5) the genotype quality (GQ) score for the offspring
should be 99; and (6) the normalized, phred-scaled genotype
likelihood (PL) scores in both parents for the three possible
genotypes 0/0, 0/1 and 1/1, where 0 is the reference allele and 1 is
the alternative allele, should be >0, >20 and >20, respectively.
Candidate de novo variants were also absent from population
controls, including a set of 107 internally sequenced controls and
the individuals whose single nucleotide variant data are reported
in the Genome Aggregation Database (gnomAD; Lek et al.,
2016). All candidate de novo variants were Sanger sequenced
using the relevant proband and parents for confirmation.
Putative recessive variants were extracted from the VCF
that met the following criteria: (1) the read depth should be
≥8 or 20 for compound heterozygous or homozygous alternate
genotype calls in the patient, respectively; (2) at least 20% and
90% of the reads in the patient should carry the alternate allele for
candidate compound heterozygous and homozygous genotypes,
respectively; (3) in the parents, at least one individual requires a
read depth ≥30; and (4) candidate recessive variants should not
be present in population controls, including a set of 107 internally
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sequenced controls and the individuals whose single nucleotide
variant data are reported in the Genome Aggregation Database
(gnomAD; Lek et al., 2016). All candidate recessive variants were
Sanger sequenced using the relevant proband and parents for
confirmation.
Framework for Identifying a Recessive
Candidate for Functional Follow Up
Studies
To prioritize validated recessive variants for functional
investigations that assess the effect of the various changes
we used the following criteria: (1) remove any candidate
in an individual already reported to have a de novo event;
(2) at least one of the recessive variants is required to be a
stop gain/loss, canonical splice site, or a small out of frame
insertion/deletion; and (3) using each of the remaining candidate
gene names as key word, functional studies were mined from
the literature described in Pubmed to determine if interactions
with pre-established PH loci and their cognate proteins was
described. Although not suggesting any given candidate
satisfying this criterion will be confirmed as a contributor to
PH etiology, in this study one gene—MOB2—was identified as
having properties warranting further analysis. Once identified,
the minor allele frequency cut off was relaxed to 2% in the
65 large cohort to survey for additional variants within this gene.
This, however, did not identify any further variants of significant
excess to that expected from control estimates within the ExAC
and gnomAD datasets (Lek et al., 2016).
Cell Culture
C2C12, HEK293, patient and control fibroblasts were cultured in
DMEM Dulbecco’s Modified Eagles Medium (DMEM; Gibcor)
supplemented with 10% fetal bovine serum (FBS) and 1%
L-glutamine at 37◦C in humidified 5% CO2.
Reprogramming of Human Fibroblasts to
Induced Pluripotent Stem Cells (iPSCs
HMGU1)
Induced pluripotent stem cells (iPSCs) were reprogrammed
from human newborn foreskin fibroblasts (CRL-2522, ATCC).
2.5 × 105 NuFF3-RQ IRR human newborn foreskin feeder
fibroblasts (GSC-3404, GlobalStem) were seeded per well of
a 6-well tissue culture dish with advanced MEM (12491015,
Thermo Fisher Scientific) supplemented with 5% HyClone
FBS (SV30160.03HI, GE Healthcare), 1% MEM NEAA and
GlutaMAX (11140050; 35050061 Thermo Fisher Scientific). On
day 1, 70%–80% confluent CRL-2522 fibroblasts were dissociated
using 0.25% Trypsin-EDTA (25200056, Life Technologies),
counted and seeded on the NuFF3-RQ cells at two different
densities: 2 × 104 cells/well and 4 × 104 cells/well. On
day 2, the medium was changed to Pluriton Reprogramming
Medium (00–0070, Stemgent) supplemented with 500 ng/mL
carrier-free B18R Recombinant Protein (03–0017, Stemgent).
On days 3–18, a cocktail of modified mRNAs (mmRNAs)
containing OCT4, SOX2, LIN28, C-MYC, and KLF mmRNAs
at a 3:1:1:1:1 stoichiometric ratio was transfected daily. For
that purpose, the mmRNAs were mixed in a total volume of
105 µL and were combined with a mix of 92 µL Opti-MEM I
Reduced Serum Medium and 13 µL Lipofectamine RNAiMAX
Transfection Reagent (31985062, Thermo Fisher Scientific) after
separate incubation at RT for 15 min. Cells were transfected for
4 h, washed and fresh reprogramming medium supplemented
with B18R was added to the cultures. The mmRNAs with the
following modifications: 5-Methyl CTP, a 150 nt poly-A tail,
ARCA cap and Pseudo-UTP were obtained from the RNA
CORE unit of the Houston Methodist Hospital. Five days after
the first transfection, the first morphological changes were
noticed, while the first iPSC colonies appeared by day 12–15.
On day 16, the medium was changed to STEMPRO hESC SFM
(A1000701, Thermo Fisher Scientific) for 5 days. Harvesting of
the iPSC colonies was performed after 40 min incubation at
37◦C with 2 mg/ml Collagenase Type IV (17104019, Thermo
Fisher Scientific) solution in DMEM/F12 (31331093, Thermo
Fisher Scientific). The iPSCs were plated on γ-irradiated mouse
embryonic fibroblasts (MEFs) and grown in STEMPRO hESC
SFM for 10 additional passages. After that the iPSCs were further
cultured in a feeder-free culture system, using mTeSR1 (05850,
StemCell Technologies) on plates coated with LDEV-Free
Geltrex (A1413302, Thermo Fisher Scientific). The control iPSC
line HMGU1 was generated in the iPSC Core Facility, Helmholtz
Center Munich.
iPSC Culture
iPSCs were cultured at 37◦C, 5% CO2 and ambient oxygen
level on Geltrex coated plates in mTeSR1 medium with daily
medium change. For passaging, iPSC colonies were incubated
with StemPro Accutase Cell Dissociation Reagent (A1110501,
Life Technologies) diluted 1:4 in PBS for 4min. Pieces of colonies
were washed off with DMEM/F12, centrifuged for 5 min at
300× g and resuspended in mTeSR1 supplemented with 10 µM
Rock inhibitor Y-27632 (2HCl; 72304, StemCell Technologies)
for the first day.
Cerebral Organoid Generation
Cerebral organoids were generated starting from 9000 single
iPSCs/well in 96 well tissue culture plates as previously described
(Lancaster et al., 2013). Upon their formation, organoids were
cultured in 10 cm dishes on an orbital shaker at 37◦C, 5% CO2
and ambient oxygen level with medium changes twice a week.
Transfection of Human Cells
Expression constructs were transiently transfected into C2C12,
HEK293 and fibroblast cells with LipofectamineTM 2000
(Invirogen, Cat. # 11668-019) according to the manufacturer’s
instructions. siRNA constructs were transiently transfected into
human fibroblasts with Lipofectamine RNAiMAX (Invitrogen,
Cat. # 13778-075) according to the manufacturer’s instructions.
Protein Extraction
Cells were lysed after 20 h post transfection in 1× phosphate
buffered saline (PBS), 1% (v/v) Triton-X100 and Complete
Protease Inhibitor (Roche) on ice for 20 min. Cell debris was
then pelleted through centrifugation at 13,000 rpm 4◦C for
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10 min. Twenty microliter of protein lysate was combined with
protein loading dye (final concentration: 50 mM Tris pH 6.8,
10% glycerol, 2% SDS, 6% 2-mercaptoethanol and 1%w/v Bromo
blue) and denatured at 95◦C for 5 min.
SDS-Page and Western Blot
Protein lysate was separated by polyacrylamide gel
electrophoresis using a mini-PROTEAN Tetra Cell system
(BioRad Laboratories, Hercules, CA, USA). The samples were
run through on a 7%–10% running gel, depending on the
size of the proteins being separated, and a 5% stacking gel.
Gel electrophoresis was performed for 1–2 h at 200 V in
running buffer (25 mM Tris base, 192 mM Glycine, 0.1% (v/v)
SDS), with 4 µL Precision Plus Protein Dual Colour Standard
(BioRad, Cat. # 161-0734) loaded to determine protein size and
monitor electrophoresis speed. Proteins were transferred to a
nitrocellulose membrane (0.25 or 0.45 micron, depending on
protein size, Pierce) using the Min Trans-Blot Electrophoretic
Transfer Cell (BioRad Laboratories, Hercules, CA, USA) at 25 V
and 50 V for 1.5 h each in transfer buffer (25 mM Tris, 0.19 M
Glycine, 10% (v/v) isopropanol). The membrane was then
blocked in 5% non-fat milk powder in PBS-T (PBS, 0.05% (v/v)
Tween20) for 30 min with shaking at 30 rpm (Ratek platform
shaker). The appropriate primary antibody was then diluted into
fresh 5% (w/v) non-fat milk powder in PBS-T and incubated
with the membrane overnight at 4◦C and 30 rpm. The following
day the membrane was washed once in PBS-T before incubation
with secondary antibody to horseradish peroxidase diluted into
fresh 5% non-fat milk powder in PBS-T for 1 h at 30 rpm. The
membrane was then washed five times for 5 min in PBS-T before
detecting bands with SuperSignal West Pico Chemiluminscent
Substrate (Pierce, Cat. # 34080) on Kodak BioMax XAR Film size
8 (Kodak, Cat. # 165-1454). Total FLNA (mouse, Abcam, Cat.
#ab188350, 1:3000) and phospho-Filamin A (Ser2152; rabbit,
Cell Signalling Technology, Cat. #4761S, 1:1000) were used to
assess phosphorylated levels of FLNA at site serine 2152.
Nonsense Mediated RNA Decay
Age-matched control and patient fibroblasts were cultured in
T-25 flask (Falcon, Cat. # 353108). Once at 80% confluency,
minimal growth media was substituted (DMEM, 1% FCS, 1%
L-glutamine) and cells were cultured for a further 12 h. After
12 h incubation media was substituted for DMEM, 10% FCS,
1% L-glutamine and either solvent alone (DMSO) or 150 µg/mL
cycloheximide (CHX) in DMSO. Cells were then incubated for
a further 4 h after which time media was removed and cells
washed with PBS, before RNA isolation. MOB2 expression was
then assayed by RT-qPCR using gene specific primers. House-
keeping normalized MOB2 expression in patient fibroblasts was
compared to control DMSO treatment using the delta-delta Ct
method.
Proteasome Inhibition
HEK293 cells plated at 80% confluency in 24-well plates (Falcon,
Cat. # 353047) were transiently transfected with a bicistronic
vector expressing both the green fluorescent protein (GFP)
and wild-type (WT) or mutant (Glu227Lys) MOB2. Twenty-
four hours after transfection media was removed and cells
gently washed with PBS. Media containing DMEM, 10% FCS,
1% L-glutamine and either solvent alone (0.01% DMSO) or
the proteasome inhibitor, 1 µM MG132 (Sigma-Aldrich, Cat.
# C2211), in DMSO for 24 h. After which point total cell lysates
were prepared and subjected to Western blot analysis using
MOB2 (mouse, LSBio, Cat. #LS-C184588, 1:5000), GFP (mouse,
OriGene, Cat. # TZ150041, 1:5000) and GAPDH (rabbit, Sigma-
Aldrich, Cat. # G9545, 1:3000).
Apoptosis Assay
Age-matched control and patient fibroblasts were cultured in
T-25 flask (Falcon, Cat. # 353108). Once at 80% confluency,
cells were treated with 0.5% trypsin (Sigma-Aldrich, Cat.
# 59418C) and reverse transfection protocol was carried out in
a 24-well plate with cells re-plated at the appropriate densities.
Media contained DMEM, 10% FCS and 1% L-glutamine and
30 nM siRNA scrambled or against MOB2 (Sigma-Aldrich,
Cat. # SIC001-10NMOL and SASI_Hs01_00177399) pre-mixed
in Lipofectamine RNAiMAX (Invitrogen, Cat. # 13778-075)
according to the manufacturer’s instructions. Samples not
treated with siRNA were only provided the Lipofectamine
RNAiMAX mixture. Twenty-four hours after transfection media
was removed, cells gently washed with PBS and then placed in
DMEM, 10% FCS, 1% L-glutamine and 200 µM camptothecin
(Merck-Millipore, Cat. # 208925). Total cell lysates were prepared
0, 8, 15 and 24 h post camptothecin treatment (200 µM) and
processed for immunoblotting using cleaved-PARP (mouse, BD-
Pharmigen, Cat. # 552596, 1:1000) and GAPDH (rabbit, Sigma-
Aldrich, Cat. # G9545, 1:3000).
Mouse Lines
All the animals used in this work were kept in the animal facility
of the Helmholtz Center Munich and Max Planck Institute of
Psychiatry. All the experimental procedures were performed
in accordance with German and European Union guidelines.
Animals were maintained on a 12 h light-dark cycle. The day
of vaginal plug was considered as embryonic day 0 (E0). In this
study the C57Bl/6J mouse line was used.
Anesthesia
To perform in utero operations, mice were anesthetized by
subcutaneous injection of a solution containing: Fentanyl
(0.05 mg/kg), Midazolam (5 mg/kg) and Medetomidine
(0.5 mg/kg). The anesthesia was terminated with a subcutaneous
injection of a solution composed of Buprenorphine (0.1 mg/kg),
Atipamezol (1.5 mg/kg) and Flumazenil (0.5 mg/kg).
In Utero Electroporation
Surgery was performed on animals in accordance with the
guidelines of Government of Upper Bavaria under licence
numbers 55.2-1-54-2532-79-11 and 55.2-1-54-2532-79-2016.
E13 pregnant dams were anesthetized and operated on as
previously described (Saito, 2006). In brief, the shaved abdomen
was opened by caesarean section in order to expose the uterine
horns. These were kept wet and warm by continuous application
of pre-warmed saline. Endotoxin free vectors—diluted to
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1.5 µg/µL—were mixed in Fast green (2.5 mg/µL, Sigma). One
microliter of mix was injected into the ventricle with the aid of
glass capillaries (self-made with a micropipette puller). DNA was
electroporated into the lateral ventricle of the telencephalon with
four pulses of 38 mV for 100 ms each. At the end of the entire
electroporation procedure, the uterine horns were repositioned
into the abdominal cavity, which was then filled with pre-warmed
saline. The abdominal wall was closed by surgical sutures
(Ethicon, Cat. # K832H). Anesthesia is reversed as described
above and animals were monitored appropriately. At E16 (3 days
post electroporation (3 dpe)) operated animals were sacrificed
by cervical dislocation. Embryos were placed in HBSS (Hank’s
Balanced Salt Solution—Gibco, Life Technologies) supplemented
with 10 mM Hepes (Gibco, Life Technologies). Embryos were
dissected and brains fixed. pSuper-GFP (Oligoengine) were
used as the control plasmid. Mob2 targeting miRNA-expressing
constructs (miRNA1 (5′-ctatactgcaggttgatgtgg-3′) and miRNA2
(5′-aataggagcaagcagcaggtg-3′)) were cloned into the pSuper-GFP
vector (Blockit, Invitrogen) according to the manufacturer’s
instructions. Plasmids were subsequently recombined into
PCAGGS destination vector (Invitrogen Gatewayr-adapted
expression vector, Cat. # K493600). shRNAs against Dchs1
and Yap have been described previously (Cappello et al.,
2013). To visualize the cilia, we electroporated a plasmid
encoding Arl13b fused with tagRFP (Arl13b-tagRFP). Nucleus-
cilia coupling was assessed in migrating neurons in the upper
bin (CP2).
Electroporation of Cerebral Organoids
Cerebral organoids were kept in antibiotic-free conditions prior
to electroporation. Electroporations were performed in cerebral
organoids at the 44 days stage after the initial plating of the cells
and fixed 7 dpe. During the electroporation cerebral organoids
were placed in an electroporation chamber (Harvard Apparatus,
Holliston, MA, USA) under a stereoscope and using a glass
microcapillary 1–2 µL of plasmid DNAs at final concentration
of 1 µg/µL was injected together with Fast Green (0.1%,
Sigma) into different ventricles of the organoids. Cerebral
organoids were subsequently electroporated with five pulses
applied at 80 V for 50 ms each at intervals of 500 ms using
the Electroportator ECM830 (Harvard Apparatus). Following
electroporation cerebral organoids were kept for additional 24 h
in antibiotic-freemedia, and then changed into the normalmedia
until fixation. Cerebral organoids were fixed using 4% PFA for
1 h at 4◦C, cryopreserved with 30% sucrose and then stored
in −20◦C. For immunofluorescence, 16 µm cryosections were
prepared.
Immunofluorescence of Mouse Cortical
Tissue
Mouse cortical tissues were fixed in 4% paraformaldehyde for
20 min at 4◦C followed by washing in PBS three times 10 min.
Tissues were allowed to sink in 30% sucrose overnight and then
embedded into molds (Polysciences, Cat. # 18646A-1) using
Tissue-Tek (Hartenstein, Cat. # TTEK) and frozen on dry ice.
Tissue was then stored at −20◦C until it was cryosectioned in
20 µm sections with a Cryostat (Leica). Sections were blocked
and permeabilized in 0.25% Triton-X100, 4% normal donkey
serum in PBS. Sections were then incubated with primary
antibodies in 0.1% Triton-X100, 4% normal donkey serum at
the following dilutions: GFP (chick, Aves Lab, Cat. # GFP-1020,
1:500). Sections were incubated overnight at 4◦C. The next day
slides were washed three times in PBS and then treated as per
the manufacturer’s instructions with the appropriate secondary
fluorophore antibodies.
Immunofluorescence of Human Cerebral
Organoids
Tissues were processed as per mouse cortical tissue. Before
sections were blocked they were post-fixed with 4% PFA for
10 mins, permeabilized in 0.3% Triton-X100 and then blocked
with 0.1% Tween, 3% BSA and 10% normal goat serum. Sections
then incubated with primary antibodies diluted in blocking
solution. GFP (chick, Aves Lab, Cat. # GFP-1020, 1:1000) and
RFP (rbb, Rockland 1:1000, Cat. # 600-401-379).
Quantification and Statistical Analysis
All analyses were performed using at least three different animals
of each genotype and the total number of cells counted is shown
below each treatment bar in each graph of the figure. Data are
represented as mean± SEM. Statistical significance was assessed
using Mann-Whitney U test, exact binomial test or one-way
ANOVA with Tukey HSD correction as indicated.
RESULTS
Identifying Candidate Loci With Biallelic
Variants in Patients With PH for Functional
Tests
To begin identifying candidate variants in PH, we analyzed
the coding region of the genome (the exome) in 65 patients
with the condition and their unaffected parents. Although
de novo variants have a strong association in neurodevelopmental
conditions, to simplify interpretation in this study we restricted
our analysis to rare biallelic variants whereby at least one of the
altered alleles was required to be a stop gain/loss or a small out of
frame insertion/deletion predictive of loss-of-function (materials
and methods). Of the 17 rare biallelic genotypes identified in
the 65 patients, only five satisfied these criteria (Supplementary
Table S1). Functional studies mined from the literature database
Pubmed, with each of the five candidate gene names as key
word, identified no evidence for any locus that indicated a
described functional interaction with pre-established PH loci and
their cognate proteins. There was, however, functional evidence
for one locus modulating immediate components of the Hippo
signaling pathway, through which the protein products of the
known PH genes FAT4 and DCHS1 signals (Cappello et al.,
2013)—MOB2.
The MOB family of proteins are both evolutionary conserved
and well-defined regulators of the Hippo signaling pathway
(Hergovich, 2012). Specifically, the sole identified interacting
partners of MOB2 are the kinases NDR1/2 of the Hippo
signaling pathway (Hergovich et al., 2005; Kohler et al., 2010;
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Hergovich, 2012). As per the Online Mendelian Inheritance in
Man database (OMIM), variants in theMOB family of genes have
not been associated with any disease to date.
Biallelic Variants Reduce MOB2 Transcript
and Protein Levels in Vitro
Patient 1203, a female, identified here with biallelic variants in
MOB2 was born to healthy non-consanguineous parents. She
first presented with epilepsy and learning difficulties. A brain
MRI scan revealed bilateral nodular PH of the lateral ventricles
(Figure 1A). Specifically, patient 1203 has two variants in
MOB2, a frameshift variant leading to the introduction of a stop
codon and a missense variant (c.207delC, p.Phe69Phefs∗127; and
c.679G > A, p.Glu227Lys; RefSeq NM_001172223 (GRCh37)),
respectively (Figure 1B). Neither variant is present within the
Genome Aggregation Database (gnomAD; Lek et al., 2016).
Sanger validations of the parental genotypes identified they were
in trans in the proband with each parent being heterozygous for
only one of the two variants (Figure 1B). Both variants show
patterns of strong evolutionary conservation (Figure 1C).
Analysis of gene constraint using information from the ExAC
database (Lek et al., 2016) showed evidence of intolerance against
LoF variants in MOB2. The constraint metric pLI for this gene
in ExAC is 0.64. While scores greater than 0.9 are regarded as
indicating extreme intolerance to LoF, the number of predicted
LoF variants in ExAC is quite small (7.3, with a single variant
actually observed). It is noteworthy that in the much larger
gnomAD database, there are only six LoF alleles in total, two
of which are located in the final exon, indicating that the
resulting transcripts are unlikely to be targeted for nonsense-
mediated decay. Taken together, this information indicates that
LoF variants inMOB2 are likely to have a deleterious effect.
The nonsense variant identified in individual 1203, c.207delC,
predicts a premature termination codon within exon two
and degradation via post-transcriptional mechanisms involving
nonsense mediated decay (NMD; Nagy and Maquat, 1998). To
formally determine if NMD is activated in response to the
c.207delC allele, quantitative RT-PCR of MOB2 transcripts was
carried out on mRNA extracted from patient 1203 fibroblasts.
Compared to MOB2 expression in two age-matched control
fibroblast lines, we identified a significant (P < 0.001) four-fold
reduction in gene expression (Figure 1D). Treating fibroblasts
with CHX, a known NMD suppressor (Carter et al., 1995),
induced a significant 2.6-fold increase (P < 0.001) in MOB2
transcript relative to vehicle-treated patient cells (Figure 1D).
To investigate any potential detrimental effects conferred by
the missense variant (c.679G > A) identified in patient 1203,
total protein lysate of HEK293 cells overexpressing the MOB2
constructs (WT or p.Glu227Lys) linked bicistronically to GFP
were analyzed by Western blot (Figure 1E). Analysis of total
protein lysate 24-h post transfection identified a significant
(P < 0.001) 10-fold reduction in mutant MOB2 protein
harboring the p.Glu227Lys change, relative to WT control
(Figure 1F).
In light of these results, we hypothesized that the missense
variant, p.Glu227Lys, destabilizes MOB2 resulting in its
degradation. In eukaryotic cells, the ubiquitin-dependent
proteasome system is the main pathway responsible for
selective intracellular protein degradation in response to
mis-folding (Nandi et al., 2006). To determine whether this
pathway was activated here, HEK293 cells expressing human
MOB2 variants (WT or p.Glu227Lys) were treated with the
proteasome inhibitor MG132. Quantitative analysis 24-h post
MG132 treatment identified a significant (P < 0.01) increase
in mutant MOB2 protein harboring the p.Glu227Lys change,
relative to vehicle-only treated cells also overexpressing this
form of protein (Figures 1E,F). No significant change in
total MOB2 abundance was detected between MG132 and
vehicle treated HEK293 cells overexpressing the WT protein
(Figures 1E,F). No change in transfection efficiency (reported
by untagged-GFP encoded on the same bicistronic vector) was
identified between any of the treatment groups (Figure 1E).
Direct assessment of the detrimental effect conferred by
the missense variant (p.Glu227Lys) in patient 1203 fibroblasts
was precluded given the undetectable levels of endogenous
MOB2 in control cells. However, reduced MOB2 levels enhance
the susceptibility of cells to apoptosis in vitro (Kohler et al.,
2010). Camptothecin is a potent inducer of apoptosis operating
through the inhibition of DNA topoisomerase (Tazi et al.,
1997). Thus, to assess altered levels of susceptibility to apoptosis
in patient 1203 fibroblasts, cells were treated for 8, 15 and
24 h with camptothecin, after which total protein lysate was
isolated and probed with an antibody against cleaved poly
ADP-ribose polymerase (PARP)—a protein cleaved directly by
caspase-3 upon apoptosis induction (Supplementary Figure S1).
Cleaved-PARP was detected 24 h post camptothecin treatment in
age-matched control fibroblasts. In contrast, cleaved-PARP was
detected 7 h earlier, at 8 h post camptothecin treatment, in patient
1203 fibroblasts (Supplementary Figure S1). This enhanced
susceptibility to apoptosis observed in patient 1203 fibroblasts,
relative to controls, was comparable to that seen in age-matched
control fibroblasts transfected with siRNA targeting MOB2
(Supplementary Figure S1).
Taken together, these data suggest that both variants
identified in MOB2 of patient 1203 are LoF with NMD and
proteasome-dependent protein degradation acting to reduce
MOB2 levels.
Mob2 Knockdown in Vivo Alters Neuronal
Distribution Within the Developing Mouse
Cortex and Induces Nucleus-Cilia
Uncoupling
Data defining brain structures that express Mob2 suggest
a potential role of this gene in cortical development (Lein
et al., 2007; Miller et al., 2014). To test this directly we
assessed the effects of knocking Mob2 down during mouse
cortical development. Specifically, we injected a bi-cistronic
vector expressing EGFP and validated miRNAs directed
against Mob2 (Supplementary Figure S2) into the ventricular
neuroepithelium of embryonic day 13 embryos (E13) using
in utero electroporation. Three days post electroporation (3 dpe;
E16) the electroporated cortices were cross-sectioned into five
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FIGURE 1 | Biallelic variants in MOB2 affect mRNA and protein stability in vitro. (A) Brain MRI scan of patient 1203, showing the presence of bilateral periventricular
nodular heterotopia (PH; red arrows). (B) Sequence traces illustrating the MOB2 sequence variants c.679G > A, present in mother and patient, and c.207delC,
present in father and patient. (C) Multiple sequence alignment (ClustalX) of the human MOB2 protein against various species. Columns are colored by conservation
and property. ∗Denotes the positions of the mutated residues—Phe69 and Glu227—substituted by each of the alleles discovered in individual 1203. (D) Mean
expression of MOB2 in age-matched controls and individual 1203 (n = 5) fibroblasts when treated with vehicle/DMSO (black circles) and cycloheximide (CHX; red
squares), as determined by real-time PCR. Expression was normalized against GAPDH and DIMT1 housekeeping genes in the same sample using the relative
standard curve method. Values were then subsequently normalized to control 1 DMSO treatment using the delta-delta Ct method. (E) HEK293 cells were transiently
transfected with a bi-cistronic vector expressing both the green fluorescent protein (GFP) and wild-type (w.t) or mutant (Glu227Lys) MOB2. At 24 h after transfection,
cells were treated with DMSO, or the proteasome inhibitor, MG132, for 24 h, after which total cell lysates were prepared and subjected to western blot analysis using
anti-MOB2, anti-GFP and anti-GAPDH as a loading control. (F) Quantifications representing three biological replicates of (E) summarizing total MOB2 protein amount
with or without MG132 treatment. Lysosomal degradation pathways may account for the remaining degraded MOB2. ∗∗P < 0.01; ∗∗∗P < 0.001, Mann-Whitney
U test.
equally sized bins (approximately corresponding to the different
two proliferative zones, intermediate zone (IZ) and upper
and lower CP) for analysis. Here, we identified an increased
fraction of EGFP-expressing cells in bin 1, corresponding to
the ventricular surface (VZ) relative to the vector-only control
cortices, with a correspondingly decrease in EGFP-expressing
cells in bin 5, corresponding to the outer CP (CP2; Figures 2A–C;
P < 0.05). No change to the total number of GFP+ cells in either
condition was observed. These patterns suggest that reduced
Mob2 levels alter the distribution of neuronal cells within the
developing cortex.
The predominant mode of radial neuronal migration within
the developing cortex is glial-guided locomotion, regulated by
coupled/coordinated movement of the cilia/centrosome and
nucleus within the neuron (Marin and Rubenstein, 2003). The
kinases NDR1/2 are known modulators of cilia/centrosome
dynamics, induced by changes in MOB2 activity in vitro
(Hergovich et al., 2009). Given this insight and the redistribution
patterns observed in cells upon decreased Mob2 levels
in utero, we hypothesized that knockdown of Mob2 could
alter cilia/centrosome dynamics. To test this, developing
mouse cortices were electroporated with a plasmid encoding
the cilia specific protein—Arl13b (Higginbotham et al.,
2012)—fused to tagRFP (Arl13b-tagRFP), together with either
the plasmid expressing EGFP/control or miRNA targetingMob2
bi-cistronically linked to EGFP (Figures 2D–G). In migrating
neurons expressing the control vector, the mean distance
between the nucleus and cilia (defined by Arl13b-tagRFP) was
3.5 µm, consistent with distances reported in previous studies
(Insolera et al., 2014). In migrating neurons expressing hair-pins
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FIGURE 2 | Mob2 knockdown alters neuronal cell distribution and nucleus-cilia coupling. Coronal micrograph sections of E16 mouse cerebral cortices
electroporated at E13 with EGFP/empty vector control (A) or miRNAs targeting Mob2 (B). (C) Quantification of the distribution of EGFP-expressing (EGFP+) cells
transfected with EGFP/empty vector alone or miRNAs targeting Mob2 3 days after electroporation (mean ± SEM). The cortex was subdivided into five equal width
bins approximately corresponding to VZ (bin 1), SVZ (bin 2), IZ (bin 3) and CP (bins 4 and 5). CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ,
ventricular zone; dpe, days post electroporation. At least three embryos were analyzed for each condition. n, total number of GFP+ cells counted per condition.
(D,E) Representative images of migrating neurons in E16 cortices (3 dpe) electroporated with EGFP/control or miRNA targeting Mob2 (green) and Arl13b-tagRFP
(red) located within bin 5 (CP2). Arrow heads indicate the cell bodies and arrows indicate the cilia labeled by Arl13b-tagRFP. Asterisks show the position of three cilia
within a neuron. (F) Quantification of the distance between the cilia and nucleus (micrometers) in neurons. Each dot represents a neuron and red lines indicate
mean ± SEM. (G) Quantification of the number of cilia in each neuron. (H,I) Micrographs sections of day 51 human cerebral organoids electroporated at day 44 with
EGFP/empty vector control or miRNA targeting MOB2 (green) and Arl13b-tagRFP (red). White arrows indicate the cilia labeled by Arl13b-tagRFP. (J) Quantification of
the percentage of cells with more than one cilium of organoids transfected with EGFP/empty vector control (GFP) or miRNAs targeting Mob2. Data taken from at
least three ventricular structures. (C,F,G) Mann-Whitney U test, (J) Exact binomial test; ∗p < 0.05, ∗∗∗p < 0.001. Scale bar represents (A,B) 100 µm, (D,E) 10 µm,
(H,I) 25 µm and (H′,H′′,I′,I′′) 5 µm.
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targetingMob2 and co-electroporated with a construct encoding
Arl13b-tagRFP, however, a significant 3-fold increase in distance
between the nucleus and cilia was observed (mean distant
11.84 µm; P < 0.001) relative to the control (Figure 2F).
Every migrating neuron contains a primary cilium attached
to the centrosome (basal body; Louvi and Grove, 2011). Of
the 102 migrating neurons analyzed that express both miRNAs
directed against Mob2 and Arl13b-tagRFP, eight had evidence
for the presence of two or more cilia, a significant increase
compared to the 98 neurons expressing both the control vector
and Arl13b-tagRFP of which two had more than one cilium
(Figure 2G; P < 0.05). Defects in cilia number were also
observed in human cerebral organoid cultures upon MOB2
knockdown, further suggesting that correct levels of this protein
are essential for maintenance of this organelle in human
neurons (Figures 2H,H′,H′′,I,I′,I′′,J). Taken together, these
results suggest that knockdown of Mob2 during E13–E16 of
murine brain development, in utero, uncouples coordinated
movement between the cilium and nucleus and may interfere
with the regulation of cilia/centrosome duplication; changes
that could ultimately impair effective neuronal migration in a
subpopulation of neurons, similarly to what occurs in PH.
Dchs1 Knockdown Induces Nucleus-Cilia
Uncoupling Within the Developing Mouse
Cortex in Vivo
FAT4 and DCHS1 are directly implicated in the cause of Van
Maldergem syndrome, a developmental disorder characterized
by PH (Cappello et al., 2013) and function upstream of
MOB2 in the Hippo signaling pathway (Hergovich, 2012).
Given this, and the altered cellular distribution and nucleus-
cilia uncoupling observed upon Mob2 knockdown in mouse
embryonic cortices, we investigated if dysregulation of other
genes involved in the regulation of the Hippo pathway and in
which mutations were associated with PH also altered these
uncoupling events. Indeed, knockdown of Dchs1 by in utero
electroporation induced cilia defects in the developing mouse
cortex (Figures 3A,A′,B,B′,C). In particular, the position and/or
number of cilia in migrating neurons was aberrant upon
Dchs1 downregulation. Strikingly, unlike the altered proliferation
phenotype induced by knockdown of this factor (Cappello
et al., 2013), this effect could not be remedied by simultaneous
reduction of Yap expression (Figures 3C,D,D′,D′′,D′′′). As
the Hippo signaling pathway is composed of two arms, the
Yap arm and Mob2 arm (Figure 5; Hergovich, 2012), these
results suggest that the changes previously observed upon
Dchs1 knockdown in utero with respect to proliferation related
directly to the regulation of Yap (Cappello et al., 2013). In
contrast, defects in nucleus-cilia coupling could be independently
determined by interference with Mob2 function in migrating
neurons.
Enhanced FLNA Phosphorylation at
Serine2152 After Mob2 Knockdown in Vitro
In addition to regulating cilia/centrosome dynamics,
Ndr1/2 kinases control actin-cytoskeletal arrangements and
inhibit murine mitogen-activated protein kinases 1 and 2
(MEKK1 andMEKK2) by binding directly to residues 1169–1488
and 342–619 at their respective carboxy-termini (Enomoto et al.,
2008). Interestingly, conditional depletion of Mekk4 in the
developing mouse forebrain impairs neuroependymal integrity
and induces PH (Sarkisian et al., 2006). The same study
also detected enhanced FlnA phosphorylation at Ser2152 in
cells conditionally depleted of Mekk4 (Sarkisian et al., 2006).
Phosphorylation at Ser2152 is an important regulator of FLNA
function (Loy et al., 2003). Given this insight we hypothesized a
link between MOB2, NDR1/2, MEKK4 and FLNA.
Although Ndr1/2 directly binds to the carboxyl-terminus of
MEKK1 and MEKK2, the study by Enomoto et al. did not
investigate the binding potential of this kinase to the additional
MEKK family proteins—i.e., MEKK3 and MEKK4 (Enomoto
et al., 2008). Human peptide sequence alignments for this family
of proteins show that the carboxyl-terminal region has the most
conserved portion, with MEKK2, MEKK3 and MEKK4 having
42%, 44% and 33% sequence identity relative to MEKK1,
respectively (Supplementary Figure S3). Notably, sites of highest
conservation co-locate with the binding domain of NDR1/2
(Supplementary Figure S3, yellow highlight).
In light of the carboxyl-terminus conservation within the
MEKK family of proteins and the reported role for Mekk4 in
regulating FlnA phosphorylation at Ser2152 (Sarkisian et al.,
2006), we next hypothesized that changes in Mob2 would alter
FlnA phosphorylation at Ser2152. Although total FlnA protein
levels were unchanged after Mob2 knockdown in C2C12 cells
in vitro, a significant 1.6-fold increase in FlnA phosphorylated
at Ser2152 was observed (P = 0.028; Figures 4A,B). In addition,
protein lysate isolated from fibroblasts of patient 1203 had a
2-fold increase in FlnA phosphorylated at Ser2152 relative to
an age-matched control (P = 0.014; Figures 4A,B). Mob2 also
regulates FlnA mRNA expression, with a significant 2.0-fold
decrease (P < 0.001) detected by qRT-PCR upon transfection
of miRNA targeted against Mob2 in C2C12 cells in vitro
(Figure 4C). Together, these results suggest that altered Mob2
expression can modulate FlnA phosphorylation and are similar
to those observed upon Mekk4 knockdown reported elsewhere
(Sarkisian et al., 2006).
DISCUSSION
Next-generation sequencing approaches in families with two
or more affected individuals have proven to be extraordinarily
effective for identifying novel recessive causes of developmental
conditions, including those of neurodevelopment (Yu et al.,
2013; Karaca et al., 2015). In non-consanguineous families
with a single affected individual (as true for the majority
of patients with PH), however, this approach is difficult,
and requires innovative strategies to investigate the relative
contribution of candidate variants. Here, we have employed a
framework that exploits reported functional interactions with
loci already implicated in PH causation as a further filter through
which to stratify putative biallelic candidates. Although not
suggesting any given candidate satisfying this criterion will be
confirmed as a contributor to PH etiology, in this study one
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FIGURE 3 | Dchs1 knockdown in the developing mouse cortex alters nucleus-cilia coupling that cannot be rescued by Yap knockdown. (A,B,D) Representative
images of migrating neurons located within bin 5 (CP2) in E16 cortices (3 dpe) electroporated with EGFP/control, miRNA targeting Yap and/or shRNA targeting Dchs1
(green) and Arl13b-tagRFP (red). White and red arrows indicate migrating neurons with correct or abnormal nucleus-cilia coupling as defined by position, respectively.
Yellow arrow head shows migrating neurons with multiple cilia. (C) Quantification of the percentage of cells with abnormal nucleus-cilia coupling. Results represented
as mean (± SEM). One-way ANOVA with Tukey HSD correction; ∗∗p < 0.001; ns, not significant. Scale bar represents (A,B,D,D′) 50 µm and (A′,B′,D′′,D′′′) 20 µm.
gene—MOB2—was identified as having properties warranting
further analysis. Functional assessment of the MOB2 variants
identified in this individual showed both to be LoF alleles. There
is evidence for constraint against LoF variants in MOB2, as
indicated by the probability of being loss-of-function intolerant
(pLI) metric in the ExAC dataset being greater than 0.1 (pLI
score = 0.64), as well as the very small number of LoF alleles
in the gnomAD database (Lek et al., 2016). This, together with
the altered cellular distribution observed after knockdown of
Mob2 within the developing mouse cortex, suggests this gene
is a potential biallelic risk-conferring candidate in PH etiology
with further functional and genetic analyses being warranted.
However, only through the identification of more patients with
MOB2 insufficiency and PH can a direct causal association be
determined.
In addition to the altered cellular distribution induced
by Mob2 knockdown, impairments in nucleus-cilia coupling
were also observed. Interestingly, this phenotype was observed
not only in the developing mouse cortex in vivo, but also
in a human specific cortical development model—cerebral
organoids (Lancaster et al., 2013)—suggesting that the role of
Mob2 in determining cilia number and position is conserved
in mammals. Given the similarities of this phenotype to that
observed after Dchs1 knockdown, a known factor of the Hippo
signaling pathway and PH etiology, we hypothesize a role
for cilia and MOB2 in cortical development, a prediction
that is strengthened by the inability to remedy the effects
of this alteration through simultaneous knockdown of Yap.
While disruption of actin dynamics and cell adhesion has
been a dominant theme in mechanistic studies on the
pathogenesis of PH to date, the link to cilia described here
could represent an unappreciated role for this organelle in
the development of some forms of this particular cortical
malformation.
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FIGURE 4 | Mob2 knockdown increases FlnA phosphorylation at Ser2152 in vitro. (A) C2C12 cells were transiently transfected with EGFP/empty vector control or
miRNAs targeting Mob2 (left panel). At 24 h after transfection, cell lysates were prepared and subjected to Western blot analysis using the indicated antibodies. Right
panel shows results for the same experiment but performed on age-matched control or patient 1203 fibroblasts. (B) Quantifications representing three biological
replicates of (A) summarizing the proportion of phosphorylated Flna at residue 2152 relative to total FLNA and normalized against the loading control Gapdh in
C2C12 or age-matched fibroblast controls. Results represented as mean (± SEM). (C) Mean (± SEM) FlnA expression in C2C12 cells expressing control or Mob2
targeting hairpins at the indicated amounts. Expression was normalized against the control using the delta-delta Ct method, as determined by real-time PCR.
Expression was normalized against Gapdh and Dimt1 housekeeping genes in the same sample using the relative standard curve method. Mann-Whitney U test;
∗P < 0.05, ∗∗P < 0.005, ∗∗∗P < 0.001.
FIGURE 5 | Alterations in the mammalian Hippo signaling pathway alter FLNA phosphorylation. A schematic depicting the potential link between the Hippo signaling
pathway and FLNA phosphorylation as outlined in this study. MST1/2 kinases (also known as “Hippo”), activated by FAT4/DCHS1, induces phosphorylation of YAP
and NDR kinases. Phosphorylation of YAP leads to its degradation in the cytoplasm, while reduced activity of MST (e.g., via loss of DCHS1 activity) attenuates YAP
phosphorylation and results in its translocation in the nucleus where it promotes changes to transcription. Phosphorylation of NDR1/2 facilitates its kinase activity.
NDR1/2 kinases are further modulated by MOB1 (not shown) and MOB2 either positively or negatively, respectively. NDR1/2 kinases regulate the phosphorylation of
the MEKK family of proteins, known modulators of FLNA phosphorylation (at site Ser2152) and activity. In addition to disrupting nucleus-cilia coupling, reduced levels
of MOB2 where seen in this study to induce changes in FLNA phosphorylation. A feature which could be mediated by the MEKK kinases given the associated
supporting information.
LATS and NDR kinases are central parts of the Hippo
signaling pathway in multicellular eukaryotes (Hergovich and
Hemmings, 2009; Pan, 2010; Sudol and Harvey, 2010; Badouel
and McNeill, 2011). Despite the importance of the NDR arm
of the Hippo pathway in regulating cellular morphogenesis in
eukaryotes (Kohler et al., 2010; Lin et al., 2011), the downstream
targets of this kinase remain largely unknown (Ultanir et al.,
2012). NDR1/2 has been experimentally identified to regulate
MEKK1/2 kinase activity (Figure 5) and MEKK4 is a known
regulator of FLNA phosphorylation (specifically at site Ser2152),
a deficiency of which has been implicated in the formation of PH
in the mouse cortex (Sarkisian et al., 2006; Enomoto et al., 2008).
To our knowledge, a link between FLNA activity and the Hippo
tumur suppressor pathway has not been described previously.
Thus in this study, the association of: (1) NDR1/2 with
MEKK1/2 carboxyl-terminal binding (Enomoto et al., 2008);
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(2) the Mekk4−/− conditional mouse knockout inducing a PH
phenotype (Sarkisian et al., 2006); and (3) the carboxyl-terminal
conserved sequence between MEKK1, 2, 3 and 4 (suggesting
NDR1/2 can bind and regulate all four MEKK kinases),
prompted investigations into the potential link between MOB2,
NDR1/2, MEKK4 and FLNA. Functional studies described
here identified a contribution from MOB2 in modulating
FLNA activity, suggesting a potential link between these two
prominent pathways implicated in PH etiology (Figure 5). Future
experiments will be required to mechanistically explore this link
and indeed determine if MEKK4, or another kinase in this
family, is involved. Nonetheless, FLNA phosphorylation at site
Ser2152 has been documented to impair FLNA turnover and
impairing actin cytoskeletal remodeling; features that ultimately
affect neuronal migration (Sarkisian et al., 2006).
Through a framework exploiting information from known
loci involved in PH, we have identified a novel candidate
locus—MOB2—conferring potential inherited risk to PH. While
functional studies and screens within larger cohorts are needed
to explore this link further, we also describe a role for
Mob2 in directing cortical development and present evidence
that suggests that these two pathways implicated in PH etiology
(i.e., FLNA and Hippo signaling) are linked.
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